Robb Stankey, PhD, our Director of Synthetic Biology, will be attending the Animal Health, Nutrition, and Technology Innovation conference, March 2-4, 2026, at Convene Sancroft St. Paul’s in London. Terra Bioforge brings extensive experience in engineering microbes for animal health applications and AHNI provides a valuable opportunity to exchange ideas, identify emerging needs in the
Our Director of Synthetic Biology Robb Stankey, PhD, will be speaking at the 75th Annual Meeting of the Society for Industrial Microbiology and Biotechnology on July 28, 2025, at the Hyatt Regency in San Fransisco. The presentation, entitled “Accelerating natural product discovery and production through biosynthetic gene cluster cloning and genome engineering” will take place
Robb Stankey, PhD, will be presenting a poster at the 5th Natural Product Discovery & Development conference on January 6th, 2025 entitled “Accelerating Natural Product Discovery & Production through Metabologenomics, BGC Cloning, & Genome Engineering”. For more information on the conference and presentation schedule, visit https://www.simbhq.org/np/
Alexander Fleming’s 1928 discovery of a mold with antibacterial properties was only the first serendipitous event on the long road to penicillin as a life-saving drug.
David Mead will be presenting a talk at the 6th International Conference on Pharmascience Research and Development, Feb 26, 2024 entitled “Accelerating Natural Product Discovery and Production with Synthetic Biology“. For more information on the conference and presentation schedule, visit https://pharma-rnd.com/
Terra Bioforge’s technology expands access to nature’s chemistry by enabling activation of cryptic or silent biosynthetic gene clusters. In another recent paper from the Beemelmanns Lab at Saarland University, researchers identified a gene cluster of interest from Actinomadura rubteroloni, the bacterial symbiont of fungus-growing termites that has anti-microbial activity. Many biosynthetic clusters like mdk are
Terra Bioforge’s technology enables rapid characterization of biosynthetic gene clusters and their corresponding natural products. In a recent paper out of the Beemelmanns Lab at Saarland University and published in Communications Chemistry, the authors surveyed the chemical diversity of macrolactam natural products. To facilitate characterization of these compounds, the researchers turned to Terra Bioforge for
Terra Bioforge’s Benjamin Knox, PhD is giving an invited talk at the Recent Advances in Fermentation Technology (RAFT) 15th meeting Oct 29 – Nov 1, 2023 at the Naples Grande Beach Resort in Naples, Florida. The talk is entitled “Raising filamentous fungal production titers with MycoDriveTM technology” taking place during the ‘Next generation strain design:
Terra Bioforge’s Benjamin Knox, PhD is giving an invited talk at the Society for Industrial Microbiology and Biotechnology 2023 Annual Meeting. The talk is entitled “Accelerating natural product discovery and production with synthetic biology” and is during the ‘Modern Natural Product Discovery’ morning session taking place Wednesday Aug 2nd from 8-11:30 AM. We hope to
Terra Bioforge’s Robb Stankey is giving a contributed talk at the American Society of Pharmacognosy Annual Meeting taking place July 22-26, 2023 in Rockville, Maryland. The talk is entitled “Directed BGC Cloning Combined with Bacterial and Fungal Expression Tools Uncover Novel Biosynthetic Mechanisms and Validate Metabologenomics”. Register before July 1st at http://aspmeetings.pharmacognosy.us/